Table 1 Inclusion and exclusion criteria
Definition | Inclusion Criteria | Exclusion Criteria | |
|---|---|---|---|
IS group | Patients taking IS medications who are vaccinated with CoronaVac vaccine or BNT162b2 vaccine | Being between 16 and 80 years old | Taking a break from the IS medication for more than one month |
Taking IS medication due to IRD | Having SARS-CoV-2 infection history | ||
Not having SARS-CoV-2 infection history and not being contacted with SARS-CoV-2 infected household previously | Being contacted with SARS-CoV-2 infected household previously | ||
Receiving 2 doses of COVID-19 vaccine and Ab determination in minimum of 2 weeks and maximum of 3 months after the second dose of vaccination | Not receiving the second dose of vaccine | ||
Ab determination before 2 weeks or after 3 months since the second dose of vaccination | |||
Having a suspected SARS-CoV-2 infection | |||
Having a history of both SARS-CoV-2 infection and COVID-19 vaccination | |||
HC group | Those who are vaccinated with CoronaVac vaccine or BNT162b2 vaccine | Being between 16 and 80 years old | Having history of IS disease or IS medication use |
Not having history of IS disease or IS medication use | Having SARS-CoV-2 infection history | ||
Not having SARS-CoV-2 infection history and not being contacted with SARS-CoV-2 infected household previously | Being contacted with SARS-CoV-2 infected household previously | ||
Receiving 2 doses of COVID-19 vaccine | Not receiving the second dose of vaccine | ||
Ab determination in minimum of 2 weeks and maximum of 3 months after the second dose of vaccination | Having a booster dose of the vaccine | ||
Ab determination before 2 weeks or after 3 months since the second dose of vaccination | |||
Having a suspected SARS-CoV-2 infection | |||
Having a history of both SARS-CoV-2 infection and COVID-19 vaccination | |||
INF group | Patients with previous SARS-CoV-2 PCR positivity in three months | Not having history of IS disease or IS medication use | Having history of IS disease or IS medication use |
Not being contacted with SARS-CoV-2 infected household previously | Ab determination before 2 weeks or after 3 months since the PCR positivity | ||
Ab determination in minimum of 2 weeks and maximum of 3 months after SARS-CoV-2 PCR positivity | Having recurrent SARS-CoV-2 infection |